Alvotech (ALVO) Return on Capital Employed (2023 - 2026)
Alvotech (ALVO) posted Return on Capital Employed of 0.42% for Q1 2026, down 93.82% on a QoQ basis from 6.84% in Q4 2025, and down 499805.0% year-over-year from N/an in Q1 2025.
Alvotech (ALVO) Return on Capital Employed (2023 - 2026) Analysis & Trends
Alvotech's Return on Capital Employed history runs 4 years deep, the most recent figure standing at 0.42% for Q1 2026.
- Quarterly Return on Capital Employed fell 499805.0% year-over-year to 0.42% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.42% (down 499805.0% YoY) and the FY2025 annual result came in at 7.45%, down 36.0% from the prior year.
- Return on Capital Employed was 0.42% for Q1 2026 at Alvotech, down from 6.84% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 6243.71% in Q1 2024 and bottomed at 13818.78% in Q1 2023.
- A 4-year average of 198.0% and a median of 0.42% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed jumped 2006249 bps — and 2026, when it plunged 499805 bps.
- Alvotech's Return on Capital Employed stood at 73.03% in 2023, then surged by 82 bps to 13.12% in 2024, then soared by 152 bps to 6.84% in 2025, then slumped by 94 bps to 0.42% in 2026.
- Business Quant data shows ALVO's Return on Capital Employed at 0.42% in Q1 2026, 6.84% in Q4 2025, and 38.39% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | 21.43% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 5.24% |
| 10 | Alvotech | 924.10 Mn | 924.10 Mn | 5.09 Mn | 0.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.42% |
| Dec 31, 2025 | 6.84% |
| Sep 30, 2025 | -38.39% |
| Jun 30, 2025 | 12.53% |
| Mar 31, 2025 | 4,998.47% |
| Dec 31, 2024 | -13.12% |
| Sep 30, 2024 | -30.17% |
| Jun 30, 2024 | 533.53% |
| Mar 31, 2024 | 6,243.71% |
| Jun 30, 2023 | -73.03% |
| Mar 31, 2023 | -13,818.78% |